In 2023, Japan's blood and blood-forming organs medicine sales were valued at $6.28 billion. From 2024, the sales in this sector are forecasted to grow steadily, reaching $6.83 billion by 2028. An analysis of year-on-year growth reveals an average increase of approximately 1.72% annually from 2024 to 2028. The compound annual growth rate (CAGR) over this period is estimated at 1.72%.

Future trends to watch for include:

The impact of aging population on blood-related healthcare needs.
Changes in healthcare policies influencing medicine pricing.
Technological advancements improving treatment efficacy.
Potential increase in investments towards disease awareness and prevention programs.